Propanc Biopharma Competitors and Similar CompaniesClear all
Propanc Biopharma's competitors and similar companies include Calithera Biosciences, Onconova Therapeutics, Immunome and Accent Therapeutics.
 Propanc Biopharma Propanc Biopharma is a development-stage healthcare company focused on developing cancer treatments for patients suffering from pancreatic and colorectal cancer. |  Calithera Biosciences Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. |  Onconova Therapeutics Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer. |  Immunome Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system. |  Accent Therapeutics Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer. | |
Founding Date | Founding Date 2007 | Founding Date 2010 | Founding Date 1998 | Founding Date 2008 | Founding Date 2017 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Camberwell, AU HQ | Locations South San Francisco, US HQ | Locations Newtown, US HQ Boston, US Newtown, US Pennington, US | Locations Exton, US HQ | Locations Lexington, US HQ |
Employees | Employees 1 | Employees 798% increase | Employees 1732% decrease | Employees 264% decrease | Employees 353% increase |
Valuation ($) | Valuation ($) 275.2 k | Valuation ($) 29.2 k | Valuation ($) 20.9 m | Valuation ($) 746.5 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $2.8m (FY, 2024) | Revenue (est.) $6.9m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($58.9m) (FY, 2025) | Net income ($39.7m) (FY, 2022) | Net income $9.2m (FY, 2024) | Net income ($212.4m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 105m | Total funding raised $ 88m | Total funding raised $ 23.8m | Total funding raised $ 103m |
For sources of this data, please see the company profile
View Company Profiles
Calithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
View companyOnconova Therapeutics
HQ
Newtown, US
Employees
17↓ 32% decrease
Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer.
View companyImmunome
HQ
Exton, US
Employees
26↓ 4% decrease
Immunome is a biotech company focused on cancer immunotherapies fueled by the human immune system.
View companyAccent Therapeutics
HQ
Lexington, US
Employees
35↑ 3% increase
Accent Therapeutics is a biopharmaceutical company engaged in the development of therapies for cancer.
View company